Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
5
|
| pubmed:dateCreated |
1985-3-11
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Nov
|
| pubmed:issn |
0301-0430
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
22
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
267-8
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:6518677-Administration, Topical,
pubmed-meshheading:6518677-Child,
pubmed-meshheading:6518677-Fludrocortisone,
pubmed-meshheading:6518677-Fluprednisolone,
pubmed-meshheading:6518677-Humans,
pubmed-meshheading:6518677-Male,
pubmed-meshheading:6518677-Middle Aged,
pubmed-meshheading:6518677-Mineralocorticoids
|
| pubmed:year |
1984
|
| pubmed:articleTitle |
Hypermineralocorticoidism due to topical application of 9 alpha-fluoroprednisolone.
|
| pubmed:publicationType |
Letter,
Case Reports
|